Overview of the Study and Key Epidemiological Findings
The article “Monkeypox: What we know (and what we do not know” by Andy Carstens, which appeared in The Scientist, has been chosen as the current epidemiological event for this assignment. The study discusses the monkeypox outbreak. The recent monkeypox outbreak started earlier this year. Evidence that monkeypox may have been spreading in the US for longer than public health experts believed is surfacing as the number of cases keeps increasing (Carstens, 2022). The World Health Organization is now contemplating declaring monkeypox a global health emergency due to hundreds of verified cases in nations where the virus is not prevalent (Carstens, 2022).
The study examines the threat posed by a monkeypox outbreak. For this examination, there is no research design. Moreover, it uses no statistical evidence to support its claims. The article’s findings demonstrate that monkeypox is a critically understudied phenomenon in the current settings. The threat of a new pandemic is straining health policy, and the healthcare sector is at a loss on what to do. A group of early monkeypox patients was enrolled in this research.
Implications for Health Policy and Population-Level Interventions
The study has a direct impact on people’s health, as it may contribute to the spread of another grave illness on a global scale. When nations collaborate to eradicate monkeypox, the disease’s impact on national and international public health and policy affects foreign policy. The recent attention given to monkeypox, however, does not imply that foreign policy priorities regarding monkeypox or global health will shift significantly (Carstens, 2022). The spread of the disease in the United States and other nations can, in theory, pose a threat to national security interests, economic power, development strategies, and humanitarian action (Bunge et al., 2022). This happens even in the absence of any mutation that makes the monkeypox virus more lethal, crippling, and contagious.
Medical experts who have dealt with smallpox viruses must emphasize the importance of monitoring developments and fully understanding the local situation. Policy frameworks must prevent the global spread of infections, plan for adequate disease surveillance, and establish appropriate systems in nations where these viruses are prevalent (Carstens, 2022).
The latest cases of COVID-19 and monkeypox are a danger to the public’s health. Some hypothesized causes of the global spread of monkeypox include travel to endemic areas, extensive deforestation, which increases human-wildlife contact, and a gradual decline in immunity associated with the termination of smallpox vaccination (Sherwat et al., 2022). The universal acceptance of diagnostics, vaccinations, medicines, and the necessity of behavior modification should all be part of this health policy.
Societal Value and Public Health Significance of the Study
This epidemiological study helps society better comprehend this emerging public health hazard. This suggests that the monkeypox virus’s true source remains unclear and requires urgent investigation. The recent monkeypox epidemic in several non-endemic nations also brought attention to the lack of understanding regarding the danger of transmission in healthcare settings (Rizk et al., 2022). Public health policy in relation to global health is discussed in the context of the monkeypox episode, alongside domestic and international politics. Monkeypox is now spreading amid a reevaluation of global health prompted by the COVID-19 pandemic (Carstens, 2022). It is crucial at this point to consider what this incident reveals and whether the epidemic is exacerbating the challenges facing global health policy.
References
Carstens, A. (2022). Monkeypox: What we know (and what we do not). The Scientist.
Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L. R., & Steffen, R. (2022). The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Neglected Tropical Diseases, 16(2), e0010141.
Rizk, J. G., Lippi, G., Henry, B. M., Forthal, D. N., & Rizk, Y. (2022). Prevention and treatment of monkeypox. Drugs, 82(9), 957-963.
Sherwat, A., Brooks, J. T., Birnkrant, D., & Kim, P. (2022). Tecovirimat and the treatment of monkeypox—Past, present, and future considerations. New England Journal of Medicine, 387(7), 579-581.